Literature DB >> 11397089

The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains.

A Honegger1, A Plückthun.   

Abstract

Immunoglobulin V(H) domain frameworks can be grouped into four distinct types, depending on the main-chain conformation of framework 1. Based on the analysis of over 200 X-ray structures representing more than 100 non-redundant V(H) domain sequences, we have come to the conclusion that the marked structural variability of the V(H) framework 1 region is caused by three residues: the buried side-chain of H6, which can be either a glutamate or a glutamine residue, the residue in position H7, which may be proline only if H6 is glutamine, and by H9 (H10 according to a new consensus nomenclature), which has to be either glycine or proline if H6 is a glutamate residue. In natural antibodies, these three residues are encoded in combinations that are compatible with each other and with the rest of the structure and therefore will yield functional molecules. However, the degenerate primer mixtures commonly used for PCR cloning of antibody fragments can and frequently do introduce out-of-context mutations to combinations that can lead to severe reduction of stability, production yield and antigen affinity. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397089     DOI: 10.1006/jmbi.2001.4664

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  A buried glutamate in the cross-β core renders β-endorphin fibrils reversible.

Authors:  Yuying Liu; Yu Zhang; Yunxiang Sun; Feng Ding
Journal:  Nanoscale       Date:  2021-12-02       Impact factor: 7.790

2.  Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.

Authors:  Adam C Fisher; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

3.  Identification of Immunoglobulin Gene Sequences from a Small Read Number of mRNA-Seq Using Hybridomas.

Authors:  Yuki Kuniyoshi; Kazumitsu Maehara; Takeshi Iwasaki; Masayasu Hayashi; Yuichiro Semba; Masatoshi Fujita; Yuko Sato; Hiroshi Kimura; Akihito Harada; Yasuyuki Ohkawa
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

4.  Determinants of the assembly and function of antibody variable domains.

Authors:  Eva Maria Herold; Christine John; Benedikt Weber; Stephan Kremser; Jonathan Eras; Carolin Berner; Sabrina Deubler; Martin Zacharias; Johannes Buchner
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

Review 5.  Understanding the Significance and Implications of Antibody Numbering and Antigen-Binding Surface/Residue Definition.

Authors:  Mathieu Dondelinger; Patrice Filée; Eric Sauvage; Birgit Quinting; Serge Muyldermans; Moreno Galleni; Marylène S Vandevenne
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

6.  A strategy for synthesis of pathogenic human immunoglobulin free light chains in E. coli.

Authors:  Paola Rognoni; Francesca Lavatelli; Simona Casarini; Giovanni Palladini; Laura Verga; Paolo Pedrazzoli; Giovanna Valentini; Giampaolo Merlini; Vittorio Perfetti
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

7.  Aggregation risk prediction for antibodies and its application to biotherapeutic development.

Authors:  Olga Obrezanova; Andreas Arnell; Ramón Gómez de la Cuesta; Maud E Berthelot; Thomas R A Gallagher; Jesús Zurdo; Yvette Stallwood
Journal:  MAbs       Date:  2015       Impact factor: 5.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.